ARTICLES BY TYLER MENICHIELLO
-
Unlocking The Pharmacological Potential Of Antibodies8/20/2025
Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains the company's Functional Antibody Selection Technology (FAST) platform and its approach to developing a pipeline of G protein-coupled receptor (GPCR) mAbs.
-
How Lumen Is Putting The "Farm" In Biopharma7/31/2025
Lumen Bioscience's SVP of production and development, Craig Behnke, Ph.D., explains how the company is cutting costs and rethinking upstream manufacturing with its algae-based production platform.
-
The Safety Potential Of Conditionally Active Biologics7/28/2025
Conditionally active biologics (CABs) are an emerging class of therapies that can reduce off-target toxicity in the clinic, and they were a topic of conversation at the 2025 BIO International Convention.
-
Governor Josh Shapiro On Supporting Biomanufacturing In Pennsylvania7/15/2025
Bioprocess Online's coverage of Governor Josh Shapiro’s fireside chat with BIO CEO, John Crowley, at the 2025 BIO International Convention.
-
How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction6/30/2025
Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.
-
Finding Compatibility In Love And CDMO Partnerships6/26/2025
Just like people, some sponsor-CDMO partnerships can be matches made in heaven. Others, not so much. See what experts have to say about finding the right CDMO and building a successful partnership together.
-
BIO2025 Recap: FDA Reducing Animal Testing, Governor Shapiro On Supporting Biopharma, Practical AI Use6/24/2025
Bioprocess Online chief editor Tyler Menichiello shares his three key takeaways from the 2025 BIO International Convention.
-
Analytics And Cross-Functional Communication: Keys To Purifying Complex Molecules5/30/2025
This summary features key takeaways from the Bioprocess Online Live event, "Challenges And Considerations For Purifying Multispecific Molecules."
-
How Modular Facility Design Can Accelerate GMP Facility Construction5/20/2025
Autolus Therapeutics' COO talks about the accelerated construction of the company's cell therapy manufacturing facility, The Nucleus.
-
A Facilities Expert Answers Audience Questions On Construction And Validation5/5/2025
Bioprocessing facility expert Herman Bozenhardt responds to some unanswered audience questions from a Pharmaceutical Online Live event on facility design and validation.